Population model of the pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in healthy subjects - Mueck, W; Becka, M; Kubitza, D (Int J Clin Pharmacol Ther, 2007)
et al.